- Venture Corp (SGX:V03) posted FY22 revenue of S$3.86bn, up 24.3% y-o-y while net profit increased 18.4% to S$369.6m.
- The revenue growth reflects robust customer demand in several technology domains and new product introductions during the year. Healthcare & Wellness, Life Science & Genomics and Test & Measurement Instrumentation technology domains were significant contributors to the overall performance.
- - Read this at SGinvestors.io -
- For 4Q22, Venture Corp's revenue rose 15.4% y-o-y (+2.2% q-o-q) to S$1.045bn while net profit of S$97.9m was up 3.5% y-o-y and flat q-o-q.
Healthy balance sheet with net cash of S$812.6m. (~15% of current market cap.)
- Venture Corp has zero debt, which stacks well against its peers in net debt position, especially in the current rising interest rate environment.
- - Read this at SGinvestors.io -
Commendable net margin of 9.6% for FY22.
- Read more at SGinvestors.io.
